Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5 IPOs That Failed You

The IPO market is starting to look like a minefield. What was once a reliable pipeline of highly anticipated market debutantes has become a sucker's bet, even for investors with the means and connections to get in on the offering price.

Here are five companies to go public this year. Let's see whether you can spot the nearly universal theme:





ArcSight (Nasdaq: ARST  )




MAKO Surgical (Nasdaq: MAKO  )




ReneSola (NYSE: SOL  )




Cascal N.V. (NYSE: HOO  )




ATA (Nasdaq: ATAI  )




The four out of five dentists who prefer sugarless gum have nothing on the five out of five IPO investors who are currently in the hole on these stocks. The losers above come from various sectors: 

  • ArcSight puts out data security and compliance software. 
  • MAKO markets robotic surgical arms and implants used in orthopedic knee procedures. 
  • ReneSola is another Chinese solar energy play. 
  • Cascal is an overseas provider of water and wastewater services. 
  • ATA is a Chinese provider of computer-based learning.

It's about time
If the companies chose to go public next year, they might have been able to avoid the current downturn. Nevertheless, companies are taking their IT security seriously. Solar energy and Chinese stocks are currently out of favor, but the growth prospects in both camps are too strong to keep them down for too much longer.  

The latest batch of IPOs isn't indicative of crummy quality -- just a sign that investors aren't ready to take chances.

Sloppy returns are the quickest way to shut off the pipeline spigot. Investors aren't stupid. If they see that recent IPOs disappointed investors, why would they pony up for the next new offering? That dries up demand, which in turn drives offering prices lower during the underwriting process.

We have no problem admitting that we gravitate to IPOs -- even now, when the niche is quite uncool. Such investments are the best way for an early adopter to latch onto promising companies early in their growth cycle. We have recommended several fresh faces in the past to Motley Fool Rule Breakers subscribers, who appreciate fast-growing companies that are disrupting their respective industries. But finding those companies isn't as easy as it sounds. Investors now have to buy IPOs for the right reasons

Before the IPO became IP-Ouch
There was a time when even mediocre IPOs could count on an opening-day pop. Even the dogs held up relatively well, with underwriters lending support to even the laggards. That climate has clearly changed. Companies no longer feel that they've left money on the table by pricing their deals too low -- instead, investors are the ones leaving money on the counter.

This doesn't mean that investors should discredit the recent wave of lackluster debutantes. Sure, some will eventually disappear into obscurity -- it happens all the time. However, better days lie ahead as market sentiment comes back around. Once these companies get a few public quarters under their belts, to remind investors what their fundamentals can achieve, their share prices should rebound.

These minefields can be dangerous to navigate. However, smart minesweepers know that now is the time to strap on the protective gear and begin the disarming process of due diligence. It's the one way to make sure that you're ready when the time comes to buy back in.

Recently, Motley Fool Rule Breakers team visited Silicon Valley. To find out about businesses with high growth rates, you can sign up now, free, to receive dispatches from The Motley Fool Innovation Tour.

Prashant Rathore updated this article, originally written by Rick Munarriz and published on February 20, 2008. Prashant does not have any financial interest in the companies mentioned above. The Fool has a disclosure policy.

Read/Post Comments (3) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 20, 2008, at 11:44 AM, noosebaum wrote:

    Just about everything is down and I think Mako Surgical has good products that have generated improved earrnings. Are you now recommending we sell MAKO?

  • Report this Comment On October 20, 2008, at 5:29 PM, babedom26 wrote:

    I don't think it's fair to call the companies who went public this year - LOSERS. The entire market is down - not just those companies who went IPO. In addition, if you did your research, you'd realize that some of these companies current stock price does not correctly reflect its success in the various industries.

  • Report this Comment On May 10, 2009, at 10:19 AM, eugenivanitcki wrote:

    Hi! I'm from Belaruss. I'm sorry for spam! Really sorry!

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 757328, ~/Articles/ArticleHandler.aspx, 10/24/2016 11:24:19 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2010 4:00 PM
ARST.DL $43.52 Down +0.00 +0.00%
Arcsight CAPS Rating: **
ATAI $3.66 Down -0.08 -2.14%
ATA CAPS Rating: No stars
CCALF.DL $0.00 Down +0.00 +0.00%
CASCAL NV CAPS Rating: *****
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****
SOL $0.98 Down +0.00 -0.13%
ReneSola CAPS Rating: *